Skip to main content

Home/ Groups/ Health Now
Matti Narkia

Women With Breast Cancer Have Low Vitamin D Levels - 0 views

  •  
    "ScienceDaily (Oct. 8, 2009) - Women with breast cancer should be given high doses of vitamin D because a majority of them are likely to have low levels of vitamin D, which could contribute to decreased bone mass and greater risk of fractures, according to scientists at the University of Rochester Medical Center." Scientists funded by the NCI analyzed vitamin D levels in each woman, and the average level was 27 nanograms per milliliter; more than two-thirds of the women had vitamin deficiency. Weekly supplementation with high doses of vitamin D -- 50,000 international units or more -- improved the levels, according to Peppone's study. The U.S. Institute of Medicine suggests that blood levels nearing 32 nanograms per milliliter are adequate.
anonymous

Tips on Pregnancy Week 6 - 0 views

  •  
    During pregnancy week 6, an baby is starting to come into view more and more similar to a little organic (even though not a human!). Dark spots must contain been formed whereas the eyes and nostrils will slowly take their shapes. There must also be little pits on either side of the skull, the place where ears are going to be shaped. There are tiny buds that will form charitable sha
anonymous

Better treatment with Erectile Dysfunction Problems - 0 views

  •  
    Sometimes but however yet a healthy person might have to deal with the Erectile Dysfunction Problems or impotence treatment . Medical drugs specially targeting your condition can to a great extent reduce the Erectile Dysfunction Problems now and then all the way to get rid of it. A well chosen erectile dysfunction treatment will really improve blood flow in the penile area and also increase the working ability of the muscles and nerves that responsible for the erection for Erectile Dysfunction Problems . Some
Matti Narkia

Experimental Drug May Work In Many Cancers - 0 views

  •  
    "SCIENTISTS have shown that a new class of cancer drugs called PARP inhibitors, currently being tested in clinical trials to treat breast and ovarian cancer could have dramatic results when used to treat other solid tumours, according to work presented at the NCRI Cancer Conference today. "
« First ‹ Previous 161 - 180 of 1801 Next › Last »
Showing 20 items per page